157 related articles for article (PubMed ID: 35511669)
1. Deregulated JAK3 mediates growth advantage and hemophagocytosis in extranodal nasal-type natural killer/T-cell lymphoma.
Picod A; Martino S; Cervera P; Manuceau G; Arca M; Wittner M; Zhang Y; Liang H; Beghi F; Solary E; Louache F; Coppo P
Haematologica; 2022 Sep; 107(9):2218-2225. PubMed ID: 35511669
[No Abstract] [Full Text] [Related]
2. [Extranodal NK/T-cell lymphoma, nasal type].
Sato Y; Yoshino T
Rinsho Ketsueki; 2007 May; 48(5):353-4. PubMed ID: 17571578
[No Abstract] [Full Text] [Related]
3. Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome.
Guedes JCR; Cunha KAPFD; Machado JRDS; Pinto LW
An Bras Dermatol; 2018 Jun; 93(3):422-425. PubMed ID: 29924244
[TBL] [Abstract][Full Text] [Related]
4. Aggressive sinonasal natural killer/T-cell lymphoma with hemophagocytic lymphohistiocytosis.
Turner JH; Loyo M; Lin SY
Am J Otolaryngol; 2012; 33(1):188-91. PubMed ID: 21764176
[TBL] [Abstract][Full Text] [Related]
5. Nasal-type NK/T-cell lymphoma presenting as hemophagocytic syndrome in an 11-year-old Mexican boy.
Brodkin DE; Hobohm DW; Nigam R
J Pediatr Hematol Oncol; 2008 Dec; 30(12):938-40. PubMed ID: 19131786
[TBL] [Abstract][Full Text] [Related]
6. An aggressive NK-cell lymphoma with hemophagocytosis.
Quinn D; Farrell K; Leach M; Bain BJ
Am J Hematol; 2021 Aug; 96(8):1047-1048. PubMed ID: 33709514
[No Abstract] [Full Text] [Related]
7. Nasal-type extranodal natural killer/T-cell lymphoma presenting as multiple cutaneous masses.
Ambur A; Foss M; Mammino J; Saeed S; Dunn C; Bhukhan A; Nathoo R
Int J Dermatol; 2023 Sep; 62(9):e476-e478. PubMed ID: 36683198
[No Abstract] [Full Text] [Related]
8. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma.
Takahashi N; Miura I; Chubachi A; Miura AB; Nakamura S
Int J Hematol; 2001 Oct; 74(3):303-8. PubMed ID: 11721967
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
10. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
11. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Donner LR
Pediatr Dev Pathol; 2008; 11(4):325; author reply 326. PubMed ID: 18839448
[No Abstract] [Full Text] [Related]
12. Extranodal NK/T-cell lymphoma nasal type mimicking pyoderma gangrenosum.
Delgado-Jimenez Y; Pérez-Gala S; Nam-Cha S; Jones-Caballero M; Fraga J; García-Díez A; Fernández-Herrera J
Acta Derm Venereol; 2007; 87(2):176-7. PubMed ID: 17340032
[No Abstract] [Full Text] [Related]
13. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
14. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
[TBL] [Abstract][Full Text] [Related]
15. An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features.
Katsaounis P; Alexopoulou A; Dourakis SP; Smyrnidis A; Marinos L; Filiotou A; Archimandritis AJ
Int J Hematol; 2008 Sep; 88(2):202-205. PubMed ID: 18654739
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
Zhang S; Li T; Zhang B; Nong L; Aozasa K
Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
[TBL] [Abstract][Full Text] [Related]
17. A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome.
Tan B; Abdelmalek C; O'Donnell JE; Toltaku T; Chaudhry R; Wang JC; Gotlieb V
Am J Case Rep; 2017 Feb; 18():160-165. PubMed ID: 28193996
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis with MEDA chemotherapy.
Li DH; Zhang XY; Du C; Zhang WH; Chang J; Ma YJ; Li ZC; Hao SG; Ding H; Tao R
Leuk Lymphoma; 2017 May; 58(5):1238-1241. PubMed ID: 27658861
[No Abstract] [Full Text] [Related]
19. [Extranodal T/NK-cell lymphoma, nasal type: a case report and review of the literature].
Khosravi Shahi P; Díaz Muñoz de la Espada VM
An Med Interna; 2005 Dec; 22(12):597-600. PubMed ID: 16454602
[TBL] [Abstract][Full Text] [Related]
20. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
